Sharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ET

Core Viewpoint - Sharps Technology, Inc. is transitioning to revenue-generating operations with its first commercial deliveries of smart safety syringe products, marking a significant milestone for the company [2][4]. Company Overview - Sharps Technology is a medical device and pharmaceutical packaging company that specializes in patented smart safety syringe products designed for the healthcare industry [4]. - The company focuses on ultra-low waste capabilities and incorporates both passive and active safety features in its syringe technologies [4]. - Sharps has a manufacturing facility in Hungary that has undergone significant upgrades to support high-volume production [2][4]. Recent Developments - The company has commenced shipments under three customer orders linked to previously announced purchase agreements, representing its first commercial deliveries [2]. - CEO Robert Hayes will present at the Life Sciences Virtual Investor Forum on June 12, 2025, providing an opportunity for real-time investor engagement [1][6]. Event Details - The Life Sciences Virtual Investor Forum will be an interactive online event where investors can ask questions in real-time [3]. - An archived webcast will be available for those unable to attend the live event [3].